Description
BSE lists 2,79,000 new equity shares of Shelter Pharma Limited for trading effective May 7, 2026, issued on preferential basis via conversion of warrants.
Summary
BSE has listed 2,79,000 new equity shares of Shelter Pharma Limited (Scrip Code: 543963) for trading effective Thursday, May 7, 2026. The shares were issued on a preferential basis to Non-Promoters at Rs. 42.25/- per share (face value Rs. 10/- + premium Rs. 32.25/-) pursuant to conversion of warrants.
Key Points
- 2,79,000 equity shares of Rs. 10/- each issued at a premium of Rs. 32.25/- per share
- Issue price: Rs. 42.25/- per share
- Issued to Non-Promoters on preferential basis via warrant conversion
- Shares rank pari-passu with existing equity shares
- ISIN: INE013V01011
- Distribution numbers: 16332793 to 16611792
Regulatory Changes
No regulatory changes. This is a routine listing notice for newly issued securities.
Compliance Requirements
- Trading members are informed that these securities are now listed and permitted to trade on BSE from May 7, 2026
- Lock-in applies to all 2,79,000 shares (Dist. Nos. 16332793–16611792) until November 15, 2026
Important Dates
- Date of Allotment: March 7, 2026
- Trading effective from: May 7, 2026
- Lock-in period ends: November 15, 2026
Impact Assessment
This is a routine listing of newly allotted shares from warrant conversion. The addition of 2,79,000 shares is a minor dilution event for Shelter Pharma Limited. All new shares are under lock-in until November 15, 2026, limiting immediate selling pressure. Broader market impact is negligible.
Impact Justification
Routine listing of new shares from warrant conversion for a small-cap company; limited broader market impact.